Publications
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Sakai-Tagawa, Y., Furusawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kashima, Y., Kikuchi, T., Yotsuyanagi, H., Suzuki, Y., & Kawaoka, Y. (2023). The Lancet Infectious Diseases, 23(5), 525-526.
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID
Scott, N., Pearmain, L., Knight, S., Brand, O., Morgan, D., Jagger, C., Harbach, S., Khan, S., Shuwa, H., Franklin, M., Kästele, V., Williams, T., Prise, I., McClure, F., Hackney, P., Smith, L., Menon, M., Konkel, J., Lawless, C., … Mann, E. (2023). European Respiratory Journal, 61(5), 2202226.
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Furusawa, Y., Sakai-Tagawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kikuchi, T., Yotsuyanagi, H., Halfmann, P., Pekosz, A., & Kawaoka, Y. (2023). The Lancet Infectious Diseases, 23(4), 402-403.
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling, W., Jittamala, P., Watson, J., Ekkapongpisit, M., Siripoon, T., Ngamprasertchai, T., Luvira, V., Pongwilai, S., Cruz, C., Callery, J., Boyd, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Piaraksa, N., Suwannasin, K., Hanboonkunupakarn, P., Hanboonkunupakarn, B., … White, N. (2023). ELife, 12.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia
Ikeda, M., Okugawa, S., Kashiwabara, K., Moritoyo, T., Kanno, Y., Jubishi, D., Hashimoto, H., Okamoto, K., Tsushima, K., Uchida, Y., Mitsumura, T., Igari, H., Tsutsumi, T., Araoka, H., Yatera, K., Yamamoto, Y., Nakamura, Y., Otani, A., Yamashita, M., … Moriya, K. (2023). International Journal of Infectious Diseases, 128, 355-363.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial
Luvira, V., Schilling, W., Jittamala, P., Watson, J., Boyd, S., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Singh, S., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Keayarsa, S., Madmanee, W., … White, N. (2023). In Research Square.
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta- analysis (vol 2, e000561, 2022)
Guerin, P., McLean, A., Rashan, S., Lawal, A., Watson, J., & Strub-Wourgaft, N. (2023). PLOS GLOBAL PUBLIC HEALTH, 3(4).
Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis.
Aung, H., Swe, L., Saito, M., Lesseps, S., Janurian, N., Tun, W., Maung Maung, B., Than, A., Watthanaworawit, W., Kaewphanderm, N., Gornsawun, G., Pyae Phyo, A., & Nosten, F. (2023). Wellcome Open Research, 8, 272.
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
Takashita, E., Yamayoshi, S., Halfmann, P., Wilson, N., Ries, H., Richardson, A., Bobholz, M., Vuyk, W., Maddox, R., Baker, D., Friedrich, T., O’Connor, D., Uraki, R., Ito, M., Sakai-Tagawa, Y., Adachi, E., Saito, M., Koga, M., Tsutsumi, T., … Kawaoka, Y. (2022). New England Journal of Medicine, 387(22), 2094-2097.
Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy
Nagai, H., Saito, M., Adachi, E., Sakai-Tagawa, Y., Yamayoshi, S., Kiso, M., Kawamata, T., Koga, M., Kawaoka, Y., Tsutsumi, T., & Yotsuyanagi, H. (2022). Japanese Journal of Infectious Diseases, 75(6), 608-611.
HESITANCY IN COVID-19 VACCINE UPTAKE IN UGANDA: Understanding Community Perceptions in Kampala, Mukono and Wakiso Districts
Kibira, D., Mulumba, M., Nanyonga, S., Baguma, C., Hasunira, R., Nsereko, I., Muhumuza, N., Musoke, J., Ssekamwa, F., & Kakinda, M. (2022). Afya na Haki.
Antibody Response to ChAdOx1-nCoV-19 Vaccine Among Recipients in Bangladesh: A Prospective Observational Study
Hoque, A., Barshan, A., Chowdhury, F., Fardous, J., Hasan, M., Khan, A., & Kabir, A. (2021). Infection and Drug Resistance, 14, 5491-5500.